Press Releases

SMITHS FALLS, ON, Nov. 27, 2019 /PRNewswire/ - On

LAVAL, QC, ROCKVILLE, MD and CAMBRIDGE, United Kingdom, Nov. 27, 2019 /PRNewswire/ - Liminal BioSciences Inc. (NASDAQ: LMNL) (TSX: LMNL) ("Liminal BioSciences" or the "Company"), a clinical-stage biopharmaceutical company focused on developing novel therapeutics to treat unmet needs in patients with l

NEW YORK, Nov. 27, 2019 /PRNewswire/ -- Thanksgiving kicks off the holiday season, a time for gathering with family, neighbors and friends we don't often get to see. For millions of Americans, Thanksgiving and the holiday season may be the first time they notice a change in a loved one's health, including their personal mobility.

MEMPHIS, Tenn., Nov. 27, 2019 /PRNewswire/ -- St. Jude Children's Research Hospital® proudly celebrates the 20th anniversary of the

11,000 Square Foot Retail Destination and Global Centre for Cannabis Education, Discovery and Community EngagementTSX | NYSE: ACB EDMONTON, Nov. 27, 2019 /PRNewswire/ - Aurora Cannabis Inc. ("Aurora") (NYSE | TSX: ACB), the Canadian company defining the future of cannabis worldwide, today announced the grand open

Company represented at Bryan Garnier Cannabis Conference HAMILTON, ON, Nov. 27, 2019 /PRNewswire/ - CTT Pharmaceutical Holdings, Inc., (the "Company" or "CTT") (OTC: CTTH), an innovative life sciences company with a portfolio of IP in novel drug delivery systems, announced today several additions to its Board of Directors and management team

VANCOUVER, Nov. 27, 2019 /PRNewswire/ - Choom™ (CSE: CHOO; OTCQB: CHOOF), an emerging adult use cannabis company that has secured one of the largest national retail networks in Canada, is pleased to announce that an Alberta provincially approved cannabis retail licensee ("Licensee") is open

TORONTO, Nov. 27, 2019 /PRNewswire/ - ADVANZ PHARMA Corp. ("ADVANZ PHARMA" or "the Company") (TSX:ADVZ), an international specialty pharmaceutical company focused on serving the needs of patients and healthcare providers around the world with enhanced access to high quality, niche-established medicines, today announced that it will hold a special meeting of shareholders

MILWAUKEE, Nov. 27, 2019 /PRNewswire/ -- FAB CBD recently announced to customers that its bundling its most popular products at prices that are virtually unheard of within the CBD industry.

CARMIEL, Israel, Nov. 27, 2019 /PRNewswire/ -- Protalix BioTherapeutics, Inc. (NYSE American: PLX) (TASE: PLX), a biopharmaceutical company focused on the development, production and commercialization of recombinant therapeutic proteins produced by its proprietary ProCellEx® plant cell-based protein expression system, today announced that it will host a key opinion leader (